Search Results 941-950 of 91016 for Metastasis

  1. Recurrent Breast Cancer Clinical Trials - Mayo Clinic Research

    This is a two arm Phase III trial in first and second-line HER2 negative patients with locally recurrent or metastatic breast cancer. The primary endpoint is ...

  2. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

    A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast ...

  3. Lung Ablation Specialty Group - Overview - Mayo Clinic

    Cryoablation — use of cold therapy and liquid nitrogen or argon gas to freeze and destroy tumor cells; Microwave ablation — use of heat therapy to heat tumors ...

  4. Sean S. Park, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Kwon, M.D., to perform translational and clinical research designed to improve clinical outcomes in metastatic cancers. Oligometastasis and stereotactic ...

  5. Glioma - Doctors and departments - Mayo Clinic

    ... metastasis, Glioma, Pituitary tumor, Chondrosarcoma, Glioblastoma, Bone metastasis, Chordoma, Choroidal melanoma. Show more areas of focus for Eric J. Lehrer ...

  6. A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma - Mayo Clinic

    A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma · Share · Facebook · Twitter.

  7. Overview - Tumor Angiogenesis and Vascular Biology Laboratory - Mayo Clinic Research

    ... metastasis, cardiovascular diseases, VEGF , cell signaling, and related studies. ... Our lab has six main research projects, focusing on angiogenesis and its role ...

  8. Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer - Mayo Clinic

    Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer · Overview · Participation ...

  9. Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma (MANTRA) - Mayo Clinic

    ... metastatic DD liposarcoma that progressed on 1 or more prior systemic ... metastases are present; ≤ 5 × ULN if liver metastases are present. Total ...

  10. Spinal Tumor And Spinal Mass Clinical Trials - Mayo Clinic Research

    ... Metastatic Vertebral Body Tumor(s) Rochester, MN. The purpose of this study is to evaluate treating painful metastatic lesions in vertebral bodies with ...